TrademarkDir
ONCOSPIRE CONSULTANTS
LIVE

Serial Number

98443088

Owner

Oncospire Consultants LLC

Attorney

Paul Martello

First Use Date

Mar 1, 2024

Filing Date

Mar 11, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ONCOSPIRE CONSULTANTS Trademark

Serial Number: 98443088 • Registration: 8129310

ONCOSPIRE CONSULTANTS is a trademark filed by Oncospire Consultants LLC on March 11, 2024. The trademark is classified under Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Oncospire Consultants LLC

1774 Cindy Ln
Hatfield, PA 19440

Entity Type: 16

Trademark Details

Filing Date

March 11, 2024

Registration Date

February 3, 2026

First Use Anywhere

March 1, 2024

First Use in Commerce

March 1, 2024

Published for Opposition

November 5, 2024

Goods & Services

Education services, namely, providing classes, seminars, workshops in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; Entertainment services, namely, providing podcasts in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; On-line journals, namely, blogs featuring information in the fields of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; Providing educational mentoring services and programs in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; Providing on-line videos featuring information in the fields of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries, not downloadable

Business consulting services in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), and clinical operations for the oncology and life sciences industries; Business management consulting, strategic planning and business advisory services provided to oncology and life sciences industries; Professional business consulting

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 3, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 15, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 15, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 8, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 8, 2025 AITU
USE AMENDMENT FILED
Jun 12, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 12, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 17, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 26, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 26, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 26, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 26, 2024 CNEA
ASSIGNED TO EXAMINER
Sep 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2024 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 21, 2024 REAP
NEW APPLICATION ENTERED
Mar 11, 2024 NWAP

Related Trademarks